MentionFox
Home › Layoffs › Outlook Therapeutics, Inc.
SEC filings · Form 8-K, Item 2.05

Outlook Therapeutics, Inc. layoffs and restructuring

Before you join, sell to or invest in Outlook Therapeutics, Inc.

MentionFox check on Outlook Therapeutics, Inc.: no red flags found in 4 sources; 4 items to note (checked 15 November 2026). mentionfox.com/c/layoffs/outlook-therapeutics

  • Note: Layoff plan disclosed Dec 2024 (filing)
  • Note: Shareholder or securities suit filed Oct 2024 (court record)
  • Note: Shareholder or securities suit filed Dec 2023 (court record)

New since last check: Layoff plan disclosed Dec 2024 (filing, first seen 14 November 2026).

Check Outlook Therapeutics, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Outlook Therapeutics, Inc.?

Every exit or restructuring plan Outlook Therapeutics, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

As of November 15, 2026, Outlook Therapeutics, Inc. has reported one exit or restructuring plan to the SEC on Form 8-K under Item 2.05, the latest filed on December 16, 2024. No WARN notice under its name is on file in the states covered here (Form 8-K, December 16, 2024).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Sphera Funds Management Ltd. also filed stake reports on 2 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Outlook Therapeutics, Inc.

Free to see. No signup.

People from Outlook Therapeutics, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Outlook Therapeutics, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest filing2024-12-16

Outlook Therapeutics, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Outlook Therapeutics have layoffs in 2024? What its filings say

Outlook Therapeutics, Inc. (CIK 1649989) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2024-12-16

Share of workforce

On December 13, 2024, the Company reduced its workforce by 5 people, or approximately 23% of the Company's existing headcount.

Expected charges

The Company estimates that it will incur approximately $ 0.3 million in restructuring charges in connection with the workforce reduction, consisting of cash-based expenses related to employee severance and notice period payments, benefits and related costs.

Timing

The Company expects that the majority of the cash payments related to the restructuring will be substantially complete by the end of the third calendar quarter 2025.

Also on the record for Outlook Therapeutics, Inc.

DateRecordFigureOur pageSource
October 13, 2026Stake report, Schedule 13G, by Empery Asset Management, LP8.73% of the class5%+ stakesSource
August 27, 2026Leadership change: Kevin Lundquist appointed, Chief Financial Officer—Leadership changesSource
August 19, 2026Stake report, Schedule 13G, by CVI Investments, Inc.9.9% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13D/A, by GMS Ventures & Investments16.4% of the class5%+ stakesSource
June 1, 2026Stake report, Schedule 13D/A, by GMS Ventures & Investments22.9% of the class5%+ stakesSource
April 24, 2026Stake report, Schedule 13G, by Mitchell P. Kopin4.99% of the class5%+ stakesSource
March 11, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
February 5, 2026Stake report, Schedule 13G/A, by Sphera Funds Management Ltd.4.69% of the class5%+ stakesSource
October 21, 2025Stake report, Schedule 13G/A, by Empery Asset Management, LP4.99% of the class5%+ stakesSource
August 14, 2025Stake report, Schedule 13G/A, by Great Point Partners, LLC4.99% of the class5%+ stakesSource
August 14, 2025Stake report, Schedule 13G/A, by TANG CAPITAL MANAGEMENT, LLC3.4% of the class5%+ stakesSource
July 31, 2025Stake report, Schedule 13G, by Empery Asset Management, LP7.57% of the class5%+ stakesSource

Keep reading

More on Outlook Therapeutics, Inc. and the records around it.

Outlook Therapeutics, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Outlook Therapeutics, Inc.?

Want the whole picture on Outlook Therapeutics, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Outlook Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Outlook Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    15 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 16 records.

Tools for this story

Each opens in a new tab, filled in for Outlook Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/outlook-therapeutics
Last updated 2026-11-15
Outlook Therapeutics, Inc. layoffs and restructuring: 1 SEC filing (2024-12-16). MentionFox, 2026-11-15. https://mentionfox.com/layoffs/outlook-therapeutics